Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Revenue (2020 - 2025)

Roivant Sciences' Revenue history spans 6 years, with the latest figure at $2.0 million for Q4 2025.

  • For Q4 2025, Revenue fell 77.83% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $5.7 million, down 73.28%, while the annual FY2025 figure was $29.1 million, 11.19% down from the prior year.
  • Revenue reached $2.0 million in Q4 2025 per ROIV's latest filing, up from $1.6 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $24.3 million in Q4 2021 to a low of $1.6 million in Q3 2025.
  • Average Revenue over 5 years is $9.9 million, with a median of $8.0 million recorded in 2024.
  • Peak YoY movement for Revenue: soared 957.22% in 2021, then plummeted 77.83% in 2025.
  • A 5-year view of Revenue shows it stood at $24.3 million in 2021, then decreased by 29.95% to $17.1 million in 2022, then decreased by 8.74% to $15.6 million in 2023, then crashed by 42.05% to $9.0 million in 2024, then tumbled by 77.83% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Revenue are $2.0 million (Q4 2025), $1.6 million (Q3 2025), and $2.2 million (Q2 2025).